Content for medical cannabis patients sits in Google's "Your Money or Your Life" category and in the FDA's line of sight. Skip disease-treatment claims, cite .gov and .edu sources, put a licensed reviewer on the byline, and spend most of your words on the logistics patients actually search for. This page is general information, not medical advice.
This is YMYL content, and Google grades it that way
Google's quality rater guidelines flag health topics as "Your Money or Your Life" pages, where thin or unsourced content gets the harshest treatment. A medical cannabis article competes in that bracket whether you like it or not. In practice that means the bar is higher on everything: who wrote it, who checked it, what it cites, and whether it hedges where the evidence hedges. A casual strain-review voice that works fine on recreational pages reads as a red flag here.
The claim line: describe the program, not a cure
The FDA has sent warning letters to cannabis and CBD companies for one thing above all others: marketing products with disease claims. "Helps with chronic pain" and "treats anxiety" are treatment claims for an unapproved drug, no matter how many studies you attach. The safe and honest pattern is to describe the regulatory reality instead. Your state lists qualifying conditions; you can say what those conditions are, explain the card process, and summarize published research in neutral terms. "Chronic pain is a qualifying condition in this state" is a fact. "Our flower relieves chronic pain" is a violation waiting for a reader with a badge.
Source from .gov and .edu, visibly
Every factual statement in a patient-facing article should trace to a source a skeptical reader can check: the state health department, FDA pages, PubMed-indexed studies, or university research centers. Link them inline, not in a pile at the bottom. Two things happen when you do this. Patients trust the page more, and your own writers stop drifting into claims the source never made, because the source is sitting right next to the sentence.
Put a licensed reviewer on the byline
A "medically reviewed by" line with a named physician, pharmacist, or nurse practitioner — credentials and a linkable profile included — changes how the page reads and how it holds up under scrutiny. The review has to be real. A reviewer who catches one overreaching sentence per article is earning the fee. If you cannot afford a physician on retainer, a consulting pharmacist reviewing your top twenty patient pages is a workable start.
Write for the questions patients actually have
Most patient search demand is logistics, not pharmacology. How to get a card. What the card costs and when it expires. Whether their condition qualifies. What to expect at a first dispensary visit. How medical purchase limits and taxes differ from recreational. These pages carry far less claim risk than effect-focused content and get searched far more, so they should be the bulk of the library.
A worked example: the qualifying-conditions page
Say you operate in a medical state and want one page to anchor patient traffic. Build "Qualifying conditions in [state], explained." Structure: the current list pulled from the state health department with a link and a last-checked date, a short plain-English note on what each condition category means for the application, the card steps, and the fees. Have your pharmacist reviewer sign off and appear on the page. No effects promised anywhere; every fact is the state's own. That page earns patient trust, ranks for dozens of condition-plus-state queries, and gives regulators nothing to object to.
Key takeaways
- Patient content is YMYL: sourcing, bylines, and review are ranking inputs, not decoration.
- Never present cannabis as treating a disease; describe state qualifying conditions and link the research instead.
- Cite .gov and .edu sources inline, with a last-checked date.
- A named physician or pharmacist reviewer beats an anonymous "medical team" line.
- Logistics content, on cards, costs, and visits, carries most of the demand and the least risk.
Frequently asked questions
Can we say cannabis treats a condition if a study supports it?
No. Presenting cannabis as a treatment for a disease is an unapproved drug claim in the FDA's eyes, and citing a study does not change that. Report what your state lists as qualifying conditions, link the research, and stop short of promising outcomes.
Who counts as a qualified medical reviewer?
A licensed physician, pharmacist, or nurse practitioner whose name, credentials, and license details appear on the page, with a real profile you can link to. A vague "reviewed by our medical team" line carries no weight with readers or with Google's quality raters.
Does a disclaimer make a risky claim safe?
No. A footer saying "not medical advice" does not neutralize a sentence that says a product treats anxiety. Regulators read the claim, not the disclaimer. Fix the sentence itself, then keep the disclaimer as context.
Want this done for your brand?
We build cannabis & CBD search visibility with full transparency, for dispensaries, brands, and MSOs.
Get a free cannabis SEO audit ›